Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra

Parkinsonism and Related Disorders

Volumn 8, Issue 5, 2002, Pages 329-341

  Knott, C ^a   Stern, G ^b   Kingsbury, A ^c   Welcher, A A ^d   Wilkin, G P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d AMGEN INC   (United States)

Author keywords

Astrocytes; Human; Microglia; Neurotrophins; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; ASTROCYTE; CADAVER; CAUDATE NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MICROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; SUBSTANTIA NIGRA;

EID: 0036092437     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(02)00008-1     Document Type: Article

References (99)

1. High potassium enhances secretion of neurotrophic factors from cultured astrocytes
2. Anterograde transport for brain-derived neurotrophic factor and its role in the brain
3. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioural deficits associated with partial nigrostriatal dopamine lesions
4. 125I]-neurotrophin-3 to mammalian brain
5. Neurotrophin trafficking by anterograde transport
6. 125I]NT-3
7. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors
8. Neurotrophin-4 selectively promotes survival of striatal neurons in organotypic slice culture
9. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor
10. The nature of the trophic action of brain-derived neurotrophic factor, des (1-3)-insulin-like growth factor and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture
11. GDNF protects mesencephalic dopaminergic neurons from axotomy-induced degeneration in the adult brain
12. TrkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: An in situ hybridisation study
13. Morphological and physiological properties of neostriatal neurons: An intracellular horseradish peroxidase study in the rat
14. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors
15. NT-3 and BDNF protect CNS neurons against metabolic/ excitotoxic insults
16. Distribution of Brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport
17. Compartmental expression of trkB receptor protein in the developing striatum
18. A Golgi study of neuronal types in the neostriatum of monkeys
19. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function
20. Aging and Parkinson's disease: Substantia nigra regional selectivity
21. Neuropathology of Parkinson's disease
22. Astrocytes and Parkinson's disease
23. Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro
24. Distribution of the neurotrophins brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 in the postnatal rat brain: An immunocytochemical study
25. Characterization of glial trkB receptors: Differential response to injury in the central and peripheral nervous systems
26. Synthesis and secretion of nerve growth factor by mouse astroglial cells in culture
27. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability
28. Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat
29. Neurotransmitters and neuromodulators in the basal ganglia
30. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo
31. The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease
32. The patients dying after long terminal phase have acidotic brains: Implications for biochemical measurements on autopsy tissue
33. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins
34. Inflammatory signals induce neurotrophin expression in human microglial cells
35. Reduced BDNA and mRNA expression in the Parkinson's disease substantia nigra
36. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nirga
37. Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon
38. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and noneuronal cells
39. Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of dopaminergic neurons in vitro
40. A direct-coloring thioicholine method for cholinesterases
41. Immunohistochemical localisation of brain-derived neurotrophic factor in adult rat brain
42. BDNF protects nigral dopamine neurons against 6 hydroxydopamine in vivo
43. Tissue pH as an indicator of tissue preservation in human post-mortem brain
44. + toxicity and oxidative stress in neonatal animals
45. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain
46. Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease
47. Inflammatory regulators in Parkinson's disease: INOS, Lipocortin-1 and cyclooxygenases-1 and -2
48. TrkC, a new member of the trk family of tyrosine protein kinases is a receptor for neurotrophin-3
49. TrkC encodes multiple neurotrophin-3 receptors with distinct biological properties and substrate specificities
50. Long-term production of neurotrophic factors by astrocyte cultures from hemiparkinsonian rat brain
51. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
52. Neurotrophic factors in the treatment of Parkinson's disease
53. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats
54. Rate of cell death in parkinsonism indicates active neuropathological process
55. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
56. Microglia in degenerative neurological disease
57. NT-3, BDNF and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression
58. Ciliary neurotrophic factors
59. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system
60. Trk B, a neural receptor protein-tyrosine kinase: Evidence for a full-length and two truncated receptors
61. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease
62. Intrastriatal infusions of BDNF: Retrodrade transport and colocalization with dopamine containing substantia nigra neurons in rat
63. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain with particular reference to Alzheimer's disease
64. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain
65. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1 and neurotrophin-3 on striatal neurons in culture
66. Long term support by injured brain extract of a sub-population of ciliary ganglion neurons purified by differential adhesion
67. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor
68. Medial nigral dopamine neurons have rich neurotrophin support in humans
69. Increased expression of trkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway
70. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: A double-label in situ hybridisation study
71. Local support cells promote survival of substantia nigra dopaminergic neurons in culture
72. The type I astrocyte subtype augments substantia nigra dopaminergic neuron survival
73. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
74. Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture
75. Reactive astrocytes: Cellular and molecular cues to biological function
76. BDNF-activated signal transduction in rat cortical glial cells
77. Neurotrophic factor receptors and their signal transduction capabilities in rat astrocytes
78. Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups
79. Glial cell line-derived neurotrophic factor but not transforming growth factor beta-3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion
80. Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular levels suggests multiple roles in the hippocampus, striatum and cortex
81. Expression of neurotrophins by midbrain dopaminergic neurons
82. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs
83. Human trks: Molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins
84. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopaminergic neurons in vivo
85. Recent progress in studies of neurotrophic factors and their clinical implications
86. Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis
87. Effects of brain-derived neurotrophic factors on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon
88. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
89. Divergent effects of astroglial and microglial secretions on neuron growth and survival
90. Alternative forms of rat TrkC with different functional capabilities
91. 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra
92. B and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma
93. Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture
94. Immunocytochemical localisation of trkB in the central nervous system of the adult rat
95. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system
96. Expression of mRNAs of multiple growth factors and receptors by astrocytes and glioma cells: Detection with reverse transcription-polymerase chain reaction
97. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment
98. Localisation of trkB tyrosine kinase immunoreactivity in the rat central nervous system
99. Localisation of neurotrophin-3-like immunoreactivity in the rat central nervous system